J Physiol Society Meetings
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Physiology in Press

First published online on July 12, 2002.
Copyright © 2002 by The Physiological Society
This Article
Right arrow Full Text (Rapid PDF)
Right arrow All Versions of this Article:
543/3/1007    most recent
2002.018846v1
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Grant, A. D.
Right arrow Articles by Brain, S. D.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Grant, A. D.
Right arrow Articles by Brain, S. D.

Received February 15, 2002
Accepted after revision June 24, 2002

Neurokinin B induces oedema formation in mouse lung via tachykinin receptor-independent mechanisms

Andrew D. Grant1, Roksana Akhtar1, Norma P. Gerard2, and Susan D. Brain3*

1 Centre for Cardiovascular Biology and Medicine, New Hunt's House, Guy's Campus, King's College, London, SE1 1UL, UK
2 Perlmutter Laboratory, The Children's Hospital, Boston, Massachusetts 02115, USA
3 Centre for Cardiovascular Biology and Medicine, New Hunt's House, Guy's Campus, King's College, London SE1 1UL, UK

* To whom correspondence should be addressed. E-mail: sue.brain{at}kcl.ac.uk.

The tachykinin neurokinin B (NKB) has been implicated in the hypertension that characterises pre-eclampsia, a condition where tissue oedema is also observed. The ability of NKB, administered intradermally or intravenously, to induce oedema formation (assessed as plasma extravasation) was examined by extravascular accumulation of intravenously injected 125I-albumin in wild-type and tachykinin NK1 receptor knockout mice. Intradermal NKB (30-300 pmol) caused dose-dependent plasma extravasation in wild-type (P < 0.05) but not NK1 knockout mice, indicating an essential role for the NK1 receptor in mediating NKB-induced skin oedema. Intravenous administration of NKB to wild-type mice produced plasma extravasation in skin, uterus, liver (P < 0.05) and particularly in the lung (P < 0.01). Surprisingly, the same doses of NKB led to plasma extravasation in the lung and liver of NK1 knockout mice. By comparison substance P induced only minimal plasma extravasation in the lungs of wild-type mice. The plasma extravasation produced by NKB in the lungs of NK1 receptor knockout mice was unaffected by treatment with the NK2 receptor antagonist SR48968 (3 mg kg-1), by the NK3 receptor antagonists SR142801 (3 mg kg-1) and SB-222200 (5 mg kg-1) or by the cyclo-oxygenase (COX) inhibitor indomethacin (20 mg kg-1). L-nitro-arginine methyl ester (15 mg kg-1), an inhibitor of eNOS, produced only a partial inhibition. We conclude that NKB is a potent stimulator of plasma extravasation through two distinct pathways: via activation of NK1 receptors, and via a novel neurokinin receptor-independent pathway specific to NKB that operates in the mouse lung. These findings are in keeping with a role for NKB in mediating plasma extravasation in diseases such as pre-eclampsia.




This article has been cited by other articles:


Home page
BloodHome page
J. W. N. Akkerman
Neurotransmittors act as platelet activators
Blood, January 15, 2008; 111(2): 476 - 476.
[Full Text] [PDF]


Home page
FASEB J.Home page
N. Clark, J. Keeble, E. S. Fernandes, A. Starr, L. Liang, D. Sugden, P. de Winter, and S. D. Brain
The transient receptor potential vanilloid 1 (TRPV1) receptor protects against the onset of sepsis after endotoxin
FASEB J, November 1, 2007; 21(13): 3747 - 3755.
[Abstract] [Full Text] [PDF]


Home page
J Mol EndocrinolHome page
T. M Lovell, R. J Woods, D. J Butlin, K. J Brayley, I. T Manyonda, J. Jarvis, S. Howell, and P. J Lowry
Identification of a novel mammalian post-translational modification, phosphocholine, on placental secretory polypeptides
J. Mol. Endocrinol., September 1, 2007; 39(3): 189 - 198.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
G. J. Graham, J. M. Stevens, N. M. Page, A. D. Grant, S. D. Brain, P. J. Lowry, and J. M. Gibbins
Tachykinins regulate the function of platelets
Blood, August 15, 2004; 104(4): 1058 - 1065.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
C. O. Pintado, F. M. Pinto, J. N. Pennefather, A. Hidalgo, A. Baamonde, T. Sanchez, and M. L. Candenas
A Role for Tachykinins in Female Mouse and Rat Reproductive Function
Biol Reprod, September 1, 2003; 69(3): 940 - 946.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
N. M. Page, N. J. Bell, S. M. Gardiner, I. T. Manyonda, K. J. Brayley, P. G. Strange, and P. J. Lowry
Characterization of the endokinins: Human tachykinins with cardiovascular activity
PNAS, May 13, 2003; 100(10): 6245 - 6250.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
P. Brownbill, N. J. Bell, R. J. Woods, P. J. Lowry, N. M. Page, and C. P. Sibley
Neurokinin B Is a Paracrine Vasodilator in the Human Fetal Placental Circulation
J. Clin. Endocrinol. Metab., May 1, 2003; 88(5): 2164 - 2170.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
A. N. Freed, S. McCulloch, T. Meyers, and R. Suzuki
Neurokinins Modulate Hyperventilation-induced Bronchoconstriction in Canine Peripheral Airways
Am. J. Respir. Crit. Care Med., April 15, 2003; 167(8): 1102 - 1108.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2002 The Physiological Society.